Mubadala opens hitech lab in Abu Dhabi
Abu Dhabi, January 22, 2012
Mubadala Healthcare has announced the official opening of its new 20,000 sq ft lab facility in Abu Dhabi which will provide one of the most comprehensive high-quality diagnostic test menus in the region.
The National Reference Laboratory (NRL) was created in partnership with and is operated by Laboratory Corporation of America (LabCorp), one of the world's largest and most renowned clinical reference laboratory networks.
The Abu Dhabi lab was set up following the 2010 launch of NRL’s debut facility in Dubai. Its goal is to help improve the breadth, coverage and efficiency of laboratory testing in the UAE.
It will serve as NRL’s regional hub and has the capacity to expand to 60,000 sq ft, said a statement from the company.
The official opening ceremony was attended by Mubadala Development Company chief financial officer, Carlos Obeid; executive director of Mubadala Healthcare and NRL chairman Suhail Mahmood Al Ansari; Labcorp chairman and CEO David King and NRL general manager Kristian Marthinsen.
Together with the significant resources of the LabCorp network, NRL offers a comprehensive menu of more than 4,000 tests.
As a result, NRL aims to offer healthcare providers in the region a one-stop solution for all of their clinical testing needs, creating an efficient and high-quality service that is closer to home, reducing both turnaround times and logistical costs compared with laboratories abroad.
Medical diagnostic testing serves a critical back-end function in the healthcare value chain, with healthcare providers significantly benefiting from test results to make informed diagnostic and treatment decisions.
It has been estimated that 70 per cent of all medical decisions regarding diagnosis and treatment are based on lab results.
To improve the current level of decision making, NRL is committed to raising quality standards in the industry by implementing international best practice procedures and quality control measures in each phase of service delivery.
“In order to develop a comprehensive, world-class healthcare offering in the UAE, we must provide home-grown solutions on a par with the highest international standards, while at the same time developing a strong knowledge base of healthcare issues that are unique to the Gulf and Mena region.
NRL is well positioned to support this important goal,” said Suhail Mahmood Al Ansari, executive director of Mubadala Healthcare.
'Our success to date and this latest milestone is testament to the strength of our partnership with LabCorp, which has brought world-class technology and expertise to the region, leading to better diagnostic support for clinicians, and ultimately a more cost-efficient service,' he added.
“LabCorp is proud to extend its best-in-class diagnostic testing expertise to the UAE, where there is great demand for more advanced infrastructure and capabilities in this field,” said
King said, “As a pioneer in genomic testing and the commercialization of new diagnostic technologies, LabCorp remained committed to partnering with NRL and Mubadala Healthcare to raise the bar on diagnostic testing infrastructure and practices in the UAE and wider region.”
The arrival of the Abu Dhabi lab marks an important expansion of NRL’s business, improving in-house testing capabilities to better meet the growing demands of the regional healthcare industry.
The new lab expands on the success of NRL’s first facility, opened at the Nucleotide Complex of Dubai Biotechnology and Research Park (Dubiotech).-TradeArabia News Service